MD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Pediatrix Medical Group Inc (MD) is not a strong buy at this moment for a beginner investor with a long-term strategy. The technical indicators are neutral, options sentiment is not strongly bullish, and there are no significant positive catalysts or recent news to drive the stock higher. Financial performance shows mixed results with revenue declining but net income and EPS improving. Analyst ratings and price target revisions are neutral to slightly negative, reflecting uncertainty in the company's future performance. Given the lack of strong buy signals and the investor's preference for long-term investments, it is better to hold off on buying this stock right now.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 41.069, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 19.895, with resistance at 21.74 and support at 18.05.
Net income and EPS increased YoY in Q4 2025, reflecting some operational improvements.
Analysts have lowered price targets, citing weaker-than-expected volumes and ACA headwinds. No recent news or significant trading trends to support a bullish case.
In Q4 2025, revenue dropped by -1.71% YoY to $493.77M, while net income increased by 10.51% YoY to $33.68M. EPS grew by 11.11% YoY to 0.4. Gross margin remained unchanged at 100%.
Analysts have a neutral to slightly negative stance on the stock. UBS lowered the price target to $22 from $23, Deutsche Bank to $19 from $21, and Truist to $21 from $24, all maintaining Hold or Neutral ratings. Concerns include weaker volumes and ACA headwinds.
